Back to BlackRock, Inc. BlackRock, Inc.

ZVRAZVRA
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ZEVRA THERAPEUTICS INC

BlackRock, Inc. holds 5.1M shares of ZVRA (ZEVRA THERAPEUTICS INC), worth $73.3M as of 2026-Q2. The position was increased (+14.6% shares). ZVRA represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$73.3M

Current Shares

5.1M

Total Value Change

+$39.2M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.1M
+14.6%
$73.3M0.0%$14.34
34
2026-Q1
Decreased
4.5M
-1.1%
$41.5M0.0%$8.91
0
2025-Q4
Increased
4.5M
+11.6%
$40.4M0.0%$8.81
32
2025-Q3
Decreased
4M
-1.1%
$38.4M0.0%$9.54
0
2025-Q2
Decreased
4.1M
-1.1%
$36M0.0%$9.00
0
2025-Q1
Increased
4.1M
+1.1%
$30.9M0.0%$7.85
29
2024-Q4
New
4.1M
-
$34M0.0%$8.21
40

Other major holders of ZVRA: FMR LLC, Woodline Partners LP, VANGUARD CAPITAL MANAGEMENT LLC, ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used